Sigma Planning’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Sigma Planning's JAZZ Position: Q3 2026 in Review
Sigma Planning increased its Jazz Pharmaceuticals (JAZZ) stake by 205% in Q3 2026, buying an estimated $1.02M and bringing the position to 6,128 shares worth $1.42M. The position accounts for 0.04% of the portfolio, ranked #459.
Sigma Planning first reported a position in JAZZ in Q2 2021 and has held it in 4 quarters since. 538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Sigma Planning held 6,128 shares of Jazz Pharmaceuticals worth $1.42M as of Q3 2026.
- Sigma Planning bought 4,119 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.02M.
- Jazz Pharmaceuticals made up 0.04% of Sigma Planning's portfolio in Q3 2026, its #459 holding.
- Sigma Planning first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
- 538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.